Concord Drugs Ltd.
BSE: 538965
Sector: Health care
NSE: N.A.
ISIN Code: INE858L01010
BSE
00:00 | 24 Apr 2020
Concord Drugs Ltd
NSE
05:30 | 01 Jan 1970
Concord Drugs Ltd
Notice : Undefined property: stdClass::$market_capital_for_nse in
/usr2/unibs/application/modules/live-market/views/scripts/company/bs-new-bse-nse-block.php on line
17
OPEN
18.45
PREVIOUS CLOSE
18.45
VOLUME
2564
52-Week high
23.15
52-Week low
11.68
P/E
32.23
Mkt Cap.(Rs cr)
14
Buy Price
17.65
Buy Qty
15.00
Sell Price
18.99
Sell Qty
192.00
OPEN
PREVIOUS CLOSE
VOLUME
52-Week high
0.00
52-Week low
0.00
P/E
32.23
Mkt Cap.(Rs cr)
0
Buy Price
Buy Qty
Sell Price
Sell Qty
OPEN
18.45
CLOSE
18.45
VOLUME
2564
52-Week high
23.15
52-Week low
11.68
P/E
32.23
Mkt Cap.(Rs cr)
14
Buy Price
17.65
Buy Qty
15.00
Sell Price
18.99
Sell Qty
192.00
OPEN
PREVIOUS CLOSE
VOLUME
52-Week high
0.00
52-Week low
0.00
P/E
32.23
Mkt Cap.(Rs cr)
14
Buy Price
Buy Qty
Sell Price
Sell Qty
Filter:
Consolidated
Standalone
Concord Drugs Ltd. (CONCORDDRUGS) - Yearly Result
Particulars ( cr)
Mar '19
Mar '18
Mar '17
Mar '16
Mar '15
Net Sales/Income From Operations
48.08
51.93
57.49
50.68
40.39
Other Income
0.09
0.00
0.15
0.20
0.00
Total Income
48.16
51.93
57.64
50.89
40.39
Total Expenditure
44.42
47.01
51.98
42.44
33.00
Operating Profit
3.74
4.92
5.66
8.45
7.39
Interest
1.59
1.88
2.42
2.57
2.72
Gross Profit
2.15
3.04
3.23
5.88
4.68
Depreciation
1.71
2.40
2.58
2.91
3.63
PBT
0.53
0.70
0.55
2.92
1.05
Tax
0.12
0.38
0.39
1.17
0.35
Net Profit/(Loss)
0.41
0.32
0.16
1.75
0.70
Minority Interest After NP
-
-
-
-
-
Net Profit after Minority Interest
-
-
-
-
-
Exceptional Items
0.00
0.00
0.00
0.00
0.00
Profit After Exceptional Items
0.41
0.32
0.16
1.75
0.70
Equity Share Capital
7.86
7.86
7.24
7.24
7.24
Reserves Excluding Revaluation Reserves
15.29
11.46
11.75
7.82
6.13
EPS
Basic EPS
0.52
0.41
0.22
2.41
0.96
Public Share Holding
No Of Shares (Crores)
0
0
0
0
0.44
Share Holding (%)
0.00
0.00
0.00
0.00
60.79
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of Shares (Crores)
0
0
0
0
0
- Per. of Shares (as a % of the total sh. of prom. and promoter group)
0.00
0.00
0.00
0.00
0.00
- Per. of Shares (as a % of the total Share Cap. of the company)
0.00
0.00
0.00
0.00
0.00
b) Non-encumbered
- Number of Shares (Crores)
0
0
0
0
0.28
- Per. of shares (as a % of the total sh. of prom. and promoter group)
0.00
0.00
0.00
0.00
100.00
- Per. of shares (as a % of the total Share Cap. of the company)
0.00
0.00
0.00
0.00
39.21
Note :
PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure.
Quick Links for Concord Drugs:
Notice : Undefined variable: mediaAbsUrl in
/usr2/unibs/application/modules/live-market/controllers/CompanyController.php on line
1690